Evidence map›Paper›PMID 38499906›Full record

ReviewMolecular neurobiology2024

Oxidative Stress and Migraine.

Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, Silvina Espada-Rubio, José A G Agúndez

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Sirtuins Contribute to the Migraine-Stroke Connection.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Ronda del Sur 10, 28500, Madrid, Spain. fjavier.jimenez@salud.madrid.org.ORCID http://orcid.org/0000-0002-7558-7323
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Ronda del Sur 10, 28500, Madrid, Spain.ORCID http://orcid.org/0000-0001-8644-2210
Elena García-MartínUniversidad de Extremadura, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.ORCID http://orcid.org/0000-0002-8094-046X
Silvina Espada-RubioSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Ronda del Sur 10, 28500, Madrid, Spain.
José A G AgúndezUniversidad de Extremadura, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.ORCID http://orcid.org/0000-0001-6895-9160
Hospital Universitario del Sureste · ESUniversidad de Extremadura · ES

Funding

Instituto de Salud Carlos III I21/01683Instituto de Salud Carlos III PI18/00540Junta de Extremadura, Mérida, Spain GR21073Junta de Extremadura, Mérida, Spain IB20134
6 · The paper itself

Abstract

The pathogenesis of migraine is not completely understood, but inflammation and oxidative stress seem to be involved, according to data from an experimental model of the disease. This narrative review summarizes data from studies on oxidative stress markers in migraine patients, case-control association studies on the possible association of candidate genes related to oxidative stress with the risk for migraine, studies showing the presence of oxidative stress in experimental models of migraine, and studies on the efficacy of antioxidant drugs in migraine therapy. Many studies have addressed the value of concentrations of prooxidant and antioxidant substances or the activity of antioxidant enzymes in different tissues (mainly in serum/plasma or in blood cells) as possible biomarkers for migraine, being thiobarbituric acid (TBA) reactive substances (TBARS) such as malonyl dialdehyde acid (MDA) and 4-hydroxynonenal, and nitric oxide (this at least during migraine attacks in patients with migraine with aura (MWA) the most reliable. In addition, the possible usefulness of antioxidant treatment is not well established, although preliminary short-term studies suggest a beneficial action of some of them such as Coenzyme Q

Indexed as

AntioxidantsMigraine DisordersOxidative StressAnimalsBiomarkersHumansAntioxidantsBiomarkersAnimal modelsAntioxidantsMigraineOxidative stressPathogenesisTherapeutics

Identifiers

PMID38499906
OpenAlexW4392901861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.